Formulary Drug Removals



Similar documents
Medications Requiring Prior Authorization for Medical Necessity

Formulary Drug Removals

Medications Requiring Prior Authorization for Medical Necessity

Formulary Drug Removals

Excluded Drug List. Drug Class Excluded Product Clinical Alternative(s) ABSORICA ONEXTON GEL ANDRODERM FORTESTA VOGELXO BRINTELLIX DESVENLAFAXINE ER

Messenger. Fall Message from the Fund s Executive Director. Michigan Conference of Teamsters Welfare Fund V OLUME 33, ISSUE 2 F ALL 2015

MEDICATION(S) SUBJECT TO STEP THERAPY

Contraceptives Available at no Cost to HealthChoice Members. HealthChoice Basic and Basic Alternative Plan Changes for Ambulance Services

Effective January 1, 2016

SAVE ON MEDICAL SERVICES and PRESCRIPTION DRUGS for ongoing conditions

2014 Valley Baptist Medicare D Formulary Step Therapy Criteria

Drug Class Excluded Product Clinical Alternative(s) ABSORICA ONEXTON GEL ANDRODERM FORTESTA VOGELXO MENTHOCIN PAD LIDOCAINE SCAR PATCH

Avoid paying too much for your prescriptions

Performance Drug List

Pharmacy Management Drug Policy

Performance Drug List

Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List

Performance Drug List

GEORGIA MEDICAID FEE-FOR-SERVICE ASTHMA and COPD AGENTS PA SUMMARY

AETNA BETTER HEALTH Prior Authorization guidelines for Step Therapy

Performance Drug List

UnitedHealthcare Group Medicare Advantage (PPO)

NALC Health Benefit Plan Formulary Drug List

Preferred Drug List. January 2014 PLAN MEMBER HEALTH CARE PROVIDER

PEBTF Drug List. July 2013 PLAN MEMBER HEALTH CARE PROVIDER

May 31, Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106

Monthly Copays. Medications must be tried for 30 days before ordering through Aspire Indiana CanaRx.

2015 EMPIRE PLAN FLEXIBLE FORMULARY DRUG LIST Administered by CVS/caremark

BayCare Health System Drug List

GEHA Drug List. July 2015 PLAN MEMBER HEALTH CARE PROVIDER

VA Premier CompleteCare Drugs that Require Step Therapy Last Updated: 09/23/2014

COVERAGE MANAGEMENT PROGRAMS

Alla chme nl A EFFECTIVE 07/01/2014 BUREAU FOR MEDICAL SERVICES WEST VIRGINIA MEDICAID PREFERRED DRUG LIST WITH PRIOR AUTHORIZATION CRITERIA

Aetna 2015 Formulary updates for self insured and custom fully insured commercial plans

Burlington Scripts Vs. Current local purchase plan. Current Copays

HMO and PPO Updates May Commercial Results


Monthly Copays. Union Copays Crestor 20MG - Tier 2,10% Eliquis 5mg - Tier 3, 20% Non-Union Copays Crestor 20MG - Tier 2, $25

Approximate Cost Reference List i for Antihyperglycemic Agents

Type 2 Diabetes Medicines: What You Need to Know

VIVA Health Custom Drug List

Prescription Drug Plan

Prescription Drug Utilization and Cost Trends,

Retiree Bulletin IMPORTANT CHANGES NYC PBA HEALTH & WELFARE. >>> Plan design updates for better benefits, lower costs

The JPMorgan Chase Prescription Drug Plan Effective January 1, 2010 (CVS Caremark web site version)

CalPERS Basic Plan Drug List

THERAPEUTIC INTERCHANGES ***Not Applied to patients <18 years of age*** Proton Pump Inhibitors

PA Start Date Therapeutic Class P&T Review Date 1/1/16 TOP$ (Single Drug Reviews) include:

DIABETES EDUCATION. *Read package insert each time you refill your medications in case there is new information SULFONYLUREAS

USP Medicare Model Guidelines v6.0 (Categories and Classes)

Add: 2 nd generation sulfonylurea or glinide or Add DPP-4 inhibitor Start or intensify insulin therapy if HbA1c goals not achieved with the above

YOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST...

612 Program Midtown Express Pharmacy

Type 2 Diabetes Medications: SGLT2 Inhibitors

Potential Savings from Generic Drugs in Upstate New York

The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.

10/30/2012. Anita King, DNP, RN, FNP, CDE, FAADE Clinical Associate Professor University of South Alabama Mobile, Alabama

Guidelines for Type 2 Diabetes Diagnosis

Anthem Blue Cross and Blue Shield Medicaid: Pharmacy and Therapeutics Advisory Committee meeting

2016 Employee Benefits Guide

2015 Travelers Prescription Drug Plan Blue Cross Blue Shield Plan and United Healthcare Choice Plus Plan

PHARMACOLOGY UPDATE: BOOMER DRUGS

Mary Bruskewitz APN, MS, RN, BC-ADM Clinical Nurse Specialist Diabetes

2015 Employee Benefits Guide

Medicines for Type 2 Diabetes A Review of the Research for Adults

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. sacubitril/valsartan film-coated tablets

Extra Value Drug List. *

Follow-up Medical History (FH-1)

Pharmacy Handbook For non-grandfathered members

Drug Formulary Update, July 2013

Pharmacy and Therapeutics Committee-approved Therapeutic Interchange

MArch The 2014 Drug Trend Report

Medicines Used to Treat Type 2 Diabetes

Diabetes Medications. Minal Patel, PharmD, BCPS

TREATMENT STRATEGIES FOR MANAGING TYPE 2 DIABETES MELLITUS. Friday, August 16, 13

Trinity Clinic Whitehouse Automatic Refill Policy April, 2007

November 5, 2015 Quarterly pharmacy formulary change notice

scriptsourcing THE NEXT 5 YEARS OF RX COSTS AND HOW THEY WILL IMPACT YOUR BOTTOM LINE ScriptSourcing Prescription Advocacy Services

Provider Network Pharmacy Listing Pharmacy Handbook Pharmacy Formulary Member Handbook Special Notices

cobra rates revised for active members nj carpenters annuity fund achieves powerful 13 percent return in 2013 funding status of pension plan improves

2015 new member prescription benefits program guide. putting your family first. MagnaCare Rx. we rise above. MagnaCareRx.com

FYI: (Acceptable range for blood glucose usually mg/dl. know your institutions policy.)

Inhaled and Oral Corticosteroids

Express Scripts/Medco Prescription Plan Information For Drug Coverage Review, Prior Authorization Process and Personalized Medicine Information

CareATC Generic Formulary Medications Available (2015)

MEDICATIONS COMMONLY USED IN CHRONIC KIDNEY DISEASE. HealthPartners Kidney Health Clinic 2011

Analyzing the Global Diabetes Market 2016

NEW MEMBERS GUIDE TO HEALTH NET HMO Important 2009 plan information for the Los Angeles Unified School District

Prior Authorization Guideline

Comparing Medications for Adults With Type 2 Diabetes Focus of Research for Clinicians

Pharmacology 260 Online Course Schedule Spring 2012

How To Treat Diabetes

Stacie L. Penkova, PharmD, MHSA, BCPS Clinical Pharmacy Manager Critical Care Pharmacy Specialist Drug Information Coordinator Pharmacology Summit

The Basics of Pharmacy Benefits Management (PBM) 2009

Transcription:

January 2015 Below is a list of medicines by drug class that have been removed from your plan s formulary. This list is effective January 1, 2015. If you continue using one of the drugs listed below and identified as a Removal after this date, you may be required to pay the full cost. If you are currently using one of the formulary drug removals, ask your doctor to choose one of the generic or brand formulary consideration options listed below. Bolded products represent formulary drug removals that are new for the 2015 plan year. Category * Allergic Reaction (Anaphylaxis) Treatment * Allergies * Nasal Steroids / Allergies * Ophthalmic Anti-infectives, Antivirals * Herpes Agents Asthma * Beta Agonists, Short-Acting Asthma * Steroid Inhalants Asthma * or Chronic Obstructive Pulmonary Disease (COPD) * Steroid / Beta Agonist Attention Deficit Hyperactivity Disorder Agents Cardiovascular Antilipemics * Fibrates Cardiovascular Antilipemics * HMG Co-A Reductase Inhibitors (HMGs or Statins) / ADRENACLICK BECONASE AQ OMNARIS QNASL RHINOCORT AQUA VERAMYST ZETONNA DYMISTA LASTACAFT VALTREX PROVENTIL HFA VENTOLIN HFA XOPENEX HFA AEROSPAN ALVESCO SYMBICORT ADDERALL XR TRICOR ADVICOR ALTOPREV LESCOL XL LIPITOR LIPTRUZET LIVALO AUVI-Q, EPIPEN, EPIPEN JR flunisolide spray, fluticasone spray, triamcinolone spray, NASONEX flunisolide spray, fluticasone spray, triamcinolone spray, or NASONEX WITH azelastine spray or PATANASE azelastine, cromolyn sodium, PATADAY, PATANOL acyclovir, valacyclovir PROAIR HFA ASMANEX, FLOVENT, PULMICORT FLEXHALER, QVAR ADVAIR, DULERA amphetamine-dextroamphetamine mixed salts ext-rel fenofibrate, fenofibric acid atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, CRESTOR, SIMCOR, VYTORIN

Chronic Obstructive Pulmonary Disease (COPD) * Anticholinergics Dermatology Skin Inflammation and Hives * Corticosteroids Biguanides Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Diabetes* Injectable Incretin Mimetics TUDORZA OLUX-E APEXICON E FORTAMET GLUMETZA RIOMET NESINA ONGLYZA KAZANO KOMBIGLYZE XR OSENI BYETTA SPIRIVA clobetasol propionate foam 0.05%, CLOBEX SPRAY desoximetasone, fluocinonide metformin, metformin ext-rel JANUVIA, TRADJENTA JANUMET, JANUMET XR, JENTADUETO BYDUREON, VICTOZA Insulins APIDRA HUMALOG NOVOLOG HUMALOG MIX 50/50 NOVOLOG MIX 70/30 HUMALOG MIX 75/25 NOVOLOG MIX 70/30 HUMULIN 70/30 NOVOLIN 70/30 HUMULIN N HUMULIN R NOVOLIN N NOVOLIN R Insulin Sensitizers Diabetes* Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Supplies 1 Erectile Dysfunction * Phosphodiesterase Inhibitors Gastrointestinal Agents * Proton Pump Inhibitors (PPIs) Glaucoma * Prostaglandin Analogs NOTE: Humulin R U-500 concentrate will not be subject to removal and will continue to be covered. ACTOS FARXIGA ACCU-CHEK STRIPS AND KITS BREEZE 2 STRIPS AND KITS CONTOUR NEXT STRIPS AND KITS CONTOUR STRIPS AND KITS FREESTYLE STRIPS AND KITS 2 All other test strips that are not ONETOUCH brand LEVITRA PREVACID PROTONIX LUMIGAN pioglitazone INVOKANA ONETOUCH ULTRA STRIPS AND KITS 1, ONETOUCH VERIO STRIPS AND KITS 1 CIALIS, VIAGRA lansoprazole, omeprazole, omeprazole-sodium bicarbonate capsule, pantoprazole, DEXILANT, NEXIUM latanoprost, travoprost, TRAVATAN Z, ZIOPTAN

Growth Hormones * Hematologic * Platelet Aggregation Inhibitors Angiotensin II Receptor Antagonists Angiotensin II Receptor Antagonist / Diuretic Calcium Channel Blockers Inflammatory Bowel Disease (IBD), Ulcerative Colitis * Aminosalicylates GENOTROPIN NUTROPIN AQ OMNITROPE SAIZEN TEV-TROPIN PLAVIX ATACAND EDARBI TEVETEN ATACAND HCT DIOVAN HCT EDARBYCLOR TEVETEN HCT NORVASC ASACOL HD DELZICOL HUMATROPE, NORDITROPIN clopidogrel, BRILINTA, EFFIENT candesartan, eprosartan, irbesartan, losartan, telmisartan, BENICAR, DIOVAN candesartan-hydrochlorothiazide, irbesartan-hydrochlorothiazide, losartan-hydrochlorothiazide, telmisartan-hydrochlorothiazide, valsartan-hydrochlorothiazide, BENICAR HCT amlodipine balsalazide, sulfasalazine, sulfasalazine delayed-rel, APRISO, LIALDA, PENTASA Multiple Sclerosis Agents* REBIF AVONEX, COPAXONE, EXTAVIA, GILENYA, TECFIDERA Musculoskeletal Agents* AMRIX cyclobenzaprine Opioid Dependence Agents * SUBOXONE FILM buprenorphine-naloxone sublingual tablet, ZUBSOLV Osteoarthritis* Viscosupplements Overactive Bladder / Incontinence * Urinary Antispasmodics Pain and Inflammation * Corticosteroids Pain and Inflammation * Nonsteroidal Antiinflammatory Drugs (NSAIDs) / Prostate Condition * Benign Prostatic Hyperplasia Agents / Sleep * Hypnotics, Non-benzodiazepines Testosterone Replacement * Androgens EUFLEXXA ORTHOVISC DETROL LA OXYTROL TOVIAZ RAYOS ARTHROTEC DUEXIS VIMOVO FLECTOR PENNSAID NAPRELAN JALYN INTERMEZZO LUNESTA ROZEREM testosterone gel ANDROGEL NATESTO TESTIM VOGELXO GEL-ONE, HYALGAN, SUPARTZ oxybutynin ext-rel, tolterodine, tolterodine ext-rel, trospium, trospium ext-rel, GELNIQUE, VESICARE dexamethasone, methylprednisolone, prednisone CELEBREX; diclofenac, meloxicam, or naproxen WITH lansoprazole, omeprazole, omeprazole/sodium bicarbonate, pantoprazole, DEXILANT, or NEXIUM diclofenac, diclofenac sodium solution, meloxicam, naproxen, VOLTAREN GEL diclofenac, meloxicam, naproxen, CELEBREX finasteride or AVODART WITH alfuzosin ext-rel, doxazosin, tamsulosin, terazosin or RAPAFLO eszopiclone, zolpidem, zolpidem ext-rel ANDRODERM, AXIRON, FORTESTA

Transplant * Immunosuppressants, Calcineurin Inhibitors Hecoria tacrolimus Category * Hepatitis C Agents* New to Market Agents 2 OLYSIO, SOVALDI and/or other Hepatitis C agents in the pipeline: Evaluation and identification of Drugs Requiring Prior Authorization for Medical Necessity will be made upon approval of the new Hepatitis C agents. New to market products and new variations of products already in the marketplace will be excluded from [or will not be added to ] the formulary until the product has been evaluated, determined to be clinically appropriate and cost effective, and approved by the CVS/caremark Pharmacy and Therapeutics Committee (or other appropriate reviewing body). The listed formulary options are subject to change. List of - Carryover from 2014 ACTOS ADVICOR ALTOPREV ALVESCO ANDROGEL ARTHROTEC ASACOL HD ATACAND ATACAND HCT BECONASE AQ BREEZE 2 STRIPS AND KITS CONTOUR NEXT STRIPS AND KITS CONTOUR STRIPS AND KITS DELZICOL DETROL LA DIOVAN HCT DYMISTA EDARBI EDARBYCLOR FLECTOR FORTAMET FREESTYLE STRIPS AND KITS 2 GENOTROPIN GLUMETZA Hecoria HUMALOG HUMALOG MIX 50/50 HUMALOG MIX 75/25 HUMULIN 70/30 HUMULIN N HUMULIN R INTERMEZZO JALYN KAZANO KOMBIGLYZE XR LASTACAFT LESCOL XL LEVITRA LIPITOR LIPTRUZET LIVALO LUMIGAN NESINA NUTROPIN AQ OLUX-E OMNARIS OMNITROPE ONGLYZA OSENI OXYTROL PLAVIX PREVACID PROTONIX QNASL RAYOS RHINOCORT AQUA RIOMET ROZEREM SAIZEN SUBOXONE FILM TESTIM TEVETEN TEVETEN HCT TEV-TROPIN TOVIAZ TRICOR TUDORZA VALTREX VENTOLIN HFA VERAMYST XOPENEX HFA ZETONNA List of - New for 2015 ACCU-CHEK STRIPS AND KITS + ADDERALL XR ADRENACLICK AEROSPAN AMRIX APEXICON E APIDRA BYETTA DUEXIS EUFLEXXA FARXIGA LUNESTA NAPRELAN NATESTO NORVASC ORTHOVISC PENNSAID PROVENTIL HFA REBIF SYMBICORT testosterone gel VIMOVO VOGELXO + Also includes all other test strips that are not ONETOUCH brand

This list represents brand products in CAPS, branded generics in upper- and lowercase, and generic products in lowercase italics. This is not an all-inclusive list of available drug options. Log in to www.caremark.com to check coverage and copay information for a specific drug. Discuss this information with your doctor or health care provider. This information is not a substitute for medical advice or treatment. Talk to your doctor or health care provider about this information and any health-related questions you have. CVS/caremark assumes no liability whatsoever for the information provided or for any diagnosis or treatment made as a result of this information. This list is subject to change. There may be additional plan restrictions. Please consult your plan for further information. Subject to applicable laws and regulations. * This list indicates the common uses for which the drug is prescribed. Some drugs are prescribed for more than one condition. 1 A OneTouch blood glucose meter will be provided at no charge by the manufacturer to those individuals currently using a meter other than OneTouch. For more information on how to obtain a blood glucose meter, call toll-free: 1-800-588-4456. Members must have CVS Caremark Mail Service Pharmacy benefits to qualify. 2 An exception process is in place for specific clinical circumstances that may require continued coverage for Freestyle diabetic test strips. If your doctor believes you have a specific clinical need for this product, he or she should fax an exception request toll-free to: 1-888-487-9257. Your plan may choose to provide an exception process for additional medications on this list and new to market agents. Your privacy is important to us. Our employees are trained regarding the appropriate way to handle your private health information. This document contains confidential and proprietary information of CVS/caremark and cannot be reproduced, distributed or printed without written permission from CVS/caremark. CVS/caremark may receive rebates, discounts and service fees from pharmaceutical manufacturers for certain listed products. This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS/caremark. Listed products are for informational purposes only and are not intended to replace the clinical judgment of the doctor. 2014 Caremark Rx, L.L.C. All rights reserved. 106-25923c 010115 www.caremark.com Document date: July 31, 2014